AMENDMENT TO RFA-DK-02-028: GEORGE M. O"BRIEN KIDNEY RESEARCH CENTERS
Release Date: January 2, 2002
NOTICE: NOT-DK-02-001
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
(http://www.niddk.nih.gov/)
The purpose of this Notice is to clarify a statement that was included
within the ELIGIBILITY REQUIREMENTS section of RFA DK-02-028. The
statement "Support will not be provided for applications with research
activities focused exclusively on basic research, or clinical research
or trials, or epidemiological research" should be replaced with the
following statement: "Support will not be provided for applications
with research activities focused exclusively on clinical research or
trials, or epidemiological research."
All other aspects of the RFA remain unchanged.
The full text of the RFA, which was published on October 1, 2001, can
be accessed at the following location:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-02-028.html.
INQUIRIES
Inquiries may be directed to:
Lawrence Agodoa, M.D.
Director, End-Stage Renal Disease Program
Division of Kidney, Urologic, and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
2 Democracy, Room 653
6707 Democracy Boulevard
Bethesda, Maryland 20892-5454
Telephone: (301) 594-9652
FAX: (301) 594-9358
E-mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH... Turning Discovery Into Health® |
||||||